Size : 10ML
| Datasheets/Manuals | Printable datasheet for OOMA00002 |
|---|
| Predicted Species Reactivity | Mouse |
|---|---|
| Product Format | LiquidNeat |
| Host | Mouse |
| Application | Blk, FA, FC, IP |
| Reconstitution and Storage | Store at ≤ -20°C. Avoid multiple freeze/thaw cycles. |
| Source | 100% Swiss Mouse, healthy, non-infected and non-immunized |
| Concentration | Total Protein: 13.6 g/dL. Acceptable Range: To Report Total IgG (by RID): 16.24 mg/mL. Acceptable Range: ≥6 mg/mL |
| Application Info | Specific methodologies have not been tested using this product. Each laboratory should determine an optimum working titer for use in its particular application. |
| Purification | Neat Serum; Filtered |
| Name | # of Products |
|---|---|
| AGA | 25 |
| AMBP | 80 |
| APOE | 81 |
| CRYAA | 45 |
| CUBN | 62 |
| DMWD | 106 |
| ELP3 | 29 |
| F7 | 49 |
| FCGRT | 41 |
| H3F3A | 189 |
| HIST4H4 | 84 |
| HNF1A | 60 |
| IMMT | 73 |
| KAT2B | 376 |
| KLK3 | 100 |
| LRP2 | 188 |
| LUC7L2 | 105 |
| NR5A2 | 62 |
| ORM1 | 47 |
| PFDN1 | 110 |
| PON1 | 56 |
| PRB3 | 19 |
| PSMA3 | 438 |
| PSMD4 | 171 |
| RBP4 | 30 |
| RYR2 | 42 |
| SMARCA4 | 392 |
| SMARCA5 | 76 |
| SRGN | 52 |
| ST13 | 53 |
| TK1 | 389 |
| UIMC1 | 122 |
| USP37 | 26 |
| YWHAG | 596 |
| Name | # of Products |
|---|---|
| Bile acid and bile salt transport | 32 |
| Bile acid metabolic process | 44 |
| Cellular response to starvation | 71 |
| Hemolysis by symbiont of host erythrocytes | 32 |
| Lipoprotein metabolic process | 108 |
| Maintenance of mitochondrion location | 29 |
| Negative regulation of apoptotic process | 538 |
| Platelet activation | 875 |
| Platelet degranulation | 443 |
| Sodium-independent organic anion transport | 28 |
| Transmembrane transport | 204 |
| Name | # of Products |
|---|---|
| Bile acid and bile salt transport | 16 |
| Bile acid metabolic process | 34 |
| Blood coagulation | 396 |
| Cellular response to starvation | 26 |
| Hemolysis by symbiont of host erythrocytes | 6 |
| Lipid metabolic process | 172 |
| Lipoprotein metabolic process | 40 |
| Maintenance of mitochondrion location | 6 |
| Negative regulation of apoptotic process | 356 |
| Negative regulation of programmed cell death | 12 |
| Platelet activation | 202 |
| Platelet degranulation | 78 |
| Positive regulation of circadian sleep/wake cycle, non-REM sleep | 6 |
| Response to mercury ion | 11 |
| Response to nutrient | 95 |
| Response to organic substance | 64 |
| Response to platinum ion | 2 |
| Response to stress | 160 |
| Small molecule metabolic process | 825 |
| Sodium-independent organic anion transport | 9 |
| Transmembrane transport | 500 |
| Transport | 555 |
| Name | # of Products |
|---|---|
| Basement membrane | 61 |
| Cytoplasm | 4549 |
| Extracellular region | 1573 |
| Extracellular space | 884 |
| Platelet alpha granule lumen | 42 |
| Protein complex | 216 |
| Name | # of Products |
|---|---|
| Antioxidant activity | 56 |
| Cell surface binding | 163 |
| Chaperone binding | 213 |
| Copper ion binding | 161 |
| DNA binding | 3958 |
| Drug binding | 264 |
| Enzyme binding | 898 |
| Fatty acid binding | 93 |
| Metal ion binding | 5514 |
| Oxygen binding | 126 |
| Protein binding | 12191 |
| Pyridoxal phosphate binding | 168 |
| Toxin binding | 50 |
| Zinc ion binding | 3721 |
| Name | # of Products |
|---|---|
| Disease mutation | 5332 |